- Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers 30 April 2021 Björn F Vahsen
- Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells 14 April 2021 Peter A C Wing
- The antigenic anatomy of SARS-CoV-2 receptor binding domain 23 March 2021 Wanwisa Dejnirattisai
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera 21 March 2021 Piyada Supasa
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera 17 March 2021 Daming Zhou
- In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages 1 March 2021 Hazel Hall-Roberts
- Breadth and function of antibody response to acute SARS-CoV-2 infection in humans 26 February 2021 Kuan-Ying A Huang
- Molecular and electrophysiological features of spinocerebellar ataxia type seven in induced pluripotent stem cells 24 February 2021 Richard J Burman
- Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia 22 February 2021 Marvin Reich
- Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages 20 February 2021 Elena Navarro-Guerrero
Research Assistant | firstname.lastname@example.org
Jane Vowles joined the Oxford University Dunn School of Pathology in 2010 as a research assistant generating iPS cells from Parkinson’s Disease patients as part of a large scale Oxford Parkinson’s Disease Centre research programme funded by Parkinson’s UK and then StemBANCC project which established a panel of iPS derived cell lines from 500 patients as a platform for cellular phenotypic drug screening with industry partners. She has also gained experience in Crispr Cas9 gene editing techniques.
She graduated in Agriculture from Reading University in 1981 and began her career working on reproductive physiology of ruminants at the Agricultural Production Research Unit at Reading.
She set up and ran a dairy farming business focusing on using high welfare standards to improve efficiency. During this period she maintained her research interests working in the development department of a small biotechnology company, TSC Cellworks now part of Caltag Medsystems, specialising in cell culture models as replacements for animals in research where she gained extensive primary human cell culture experience.
To broaden her experience she moved to MRC Mammalian Genetics Unit, Harwell as a microinjectionist and culturing mouse ES cells.